Eden Research plc (LSE:EDEN) has achieved a key regulatory milestone after receiving approval in Chile for its fungicide Novellus+, marking the company’s first authorisation in South America.
The approval allows Novellus+ to be used on both wine and table grapes to combat grey mould and powdery mildew. The product will be marketed exclusively in Chile by Sipcam Chile SpA. Novellus+ provides residue-free disease control and can be applied up to one day before harvest, an attribute that aligns well with export-focused grape producers operating under strict residue limits.
Chile represents a strategically important market for Eden, given its position as one of the world’s leading exporters of wine and table grapes and its increasing adoption of biological and sustainable crop protection solutions. The authorisation gives Eden direct access to a sizeable and growing market while reinforcing its exposure to regions where regulators and growers are actively encouraging reduced reliance on conventional chemical fungicides.
Eden said the approval supports its longer-term growth strategy, with plans to expand the use of Novellus+ into other high-value crops in Chile over time. While the company continues to report revenue growth, its financial outlook remains constrained by ongoing profitability and cash flow pressures. Short-term technical indicators point to positive momentum, though elevated valuation risks persist due to losses and the absence of dividend income.
More about Eden Research plc
Eden Research plc is an AIM-listed agricultural technology company focused on the development of sustainable biopesticide and biocontrol products. Its portfolio is designed to deliver environmentally friendly, residue-free crop protection solutions for high-value crops, addressing increasing regulatory, consumer, and exporter demand for biological alternatives to traditional chemical pesticides.
Leave a Reply